Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Methacholine PC20 in African Americans and whites with asthma with homozygous genotypes at ADRB2 codon 16.

Blake K, Cury JD, Hossain J, Tantisira K, Wang J, Mougey E, Lima J.

Pulm Pharmacol Ther. 2013 Jun;26(3):342-7. doi: 10.1016/j.pupt.2013.01.009. Epub 2013 Feb 4.

2.

Pharmacogenetics: implications of race and ethnicity on defining genetic profiles for personalized medicine.

Ortega VE, Meyers DA.

J Allergy Clin Immunol. 2014 Jan;133(1):16-26. doi: 10.1016/j.jaci.2013.10.040. Review.

3.

Effect of ADRB2 polymorphisms on response to longacting beta2-agonist therapy: a pharmacogenetic analysis of two randomised studies.

Bleecker ER, Postma DS, Lawrance RM, Meyers DA, Ambrose HJ, Goldman M.

Lancet. 2007 Dec 22;370(9605):2118-25. Review.

PMID:
18156033
4.

Controversies regarding long-acting β2-agonists.

Khianey R, Oppenheimer J.

Curr Opin Allergy Clin Immunol. 2011 Aug;11(4):345-54. doi: 10.1097/ACI.0b013e328348a82e. Review.

PMID:
21659855
5.

Pharmacogenetics of beta2-agonist drugs in asthma.

Taylor DR.

Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):247-58. Review.

PMID:
17085797
6.

Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones.

Pera T, Penn RB.

Pharmacol Ther. 2016 Aug;164:82-96. doi: 10.1016/j.pharmthera.2016.04.002. Epub 2016 Apr 23. Review.

Supplemental Content

Support Center